SciVision Biotech Inc. (TPE:1786)
Taiwan · Delayed Price · Currency is TWD 109.00
-0.50 (-0.46%)
Oct 9, 2025, 1:30 PM CST
SciVision Biotech Market Cap
SciVision Biotech has a market cap or net worth of 7.87 billion as of October 10, 2025. Its market cap has decreased by -8.55% in one year.
Market Cap
7.87B
Enterprise Value
7.46B
Revenue
891.22M
Ranking
n/a
PE Ratio
49.42
Stock Price
109.00
Market Cap Chart
Since December 29, 2010, SciVision Biotech's market cap has increased from 1.23B to 7.87B, an increase of 540.53%. That is a compound annual growth rate of 13.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 7.87B | 5.39% |
| Dec 31, 2024 | 7.47B | 42.10% |
| Dec 29, 2023 | 5.25B | 46.46% |
| Dec 30, 2022 | 3.59B | 9.27% |
| Dec 30, 2021 | 3.28B | -12.78% |
| Dec 31, 2020 | 3.76B | -9.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |